GI Mapping, or the Gastrointestinal Microbial Assay Plus (GI-MAP), is a DNA-based stool analysis that provides a detailed view of the gut microbiome and overall gastrointestinal health. Using advanced quantitative PCR (qPCR) technology, it accurately identifies and quantifies bacteria, viruses, parasites, and fungi, as well as key markers of inflammation, immune function, and digestion. This allows clinicians to uncover imbalances and potential root causes of chronic health issues such as IBS, autoimmune conditions, mood disorders, and skin problems. By offering a precise, personalized profile of gut health, GI Mapping helps guide targeted interventions and monitor progress over time, making it a powerful tool in functional and integrative medicine.